Aris Kaltsas: What GLP-1 Receptor Agonists and Tirzepatide Do to Male Reproduction
Aris Kaltsas, Assistant Professor of Urology and Andrology at National and Kapodistrian University of Athens, shared a post on LinkedIn about a paper he co-authored with colleagues published in the Journal of Clinical Medicine:
” ‘I’m on semaglutide, and we are trying for a baby. Is that a problem?’
More and more men ask this. The honest answer is shorter than they expect: we do not know enough.
Our new review in the Journal of Clinical Medicine examines what GLP-1 receptor agonists and tirzepatide do to male reproduction.
Three things stood out.
- In men with obesity or type 2 diabetes, total testosterone often rises. Free testosterone is less consistent. The small studies available did not show the gonadotropin suppression expected with exogenous testosterone.
- Some semen parameters improve, but the studies are small and the effect cannot be separated from weight loss itself. In a randomized weight-maintenance substudy, the semen gains followed the weight, and no additional benefit from liraglutide was detected.
- For the outcomes couples care about (conception, ART results, pregnancy, live birth, offspring health), we found no adequately powered prospective study. For tirzepatide, we found no controlled study of semen or fertility outcomes at all.
Better hormones are not the same as proven fertility benefit. These drugs belong to metabolic indications, not to the infertility clinic. And when a man wants children, testosterone monotherapy is still the thing to avoid.
We also propose a counseling framework built on a question that is asked too rarely: what are your fertility plans? It is pragmatic, non-validated and not guideline-endorsed. We say so in the paper, and we hope someone will test it.”
Title: GLP-1 Receptor Agonists and Tirzepatide in Men Seeking Fertility: A Structured Narrative Review and Proposed Clinical Framework
Authors: Aris Kaltsas, Vasileios Gkioxaris, Timoleon Giannakas, Athanasios Zachariou, Fotios Dimitriadis, Nikolaos Sofikitis, Michael Chrisofos
You can read the Full Article in the Journal of Clinical Medicine.

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 22, 2026, 17:01Insights from ISFP 2026
-
Nov 22, 2026, 16:17Khalil Faaed: The Dark Center of the Oocyte
-
Nov 22, 2026, 16:10Jyoti Gupta: Proud to Join Cloudnine Fertility, Golf Course Road, Gurugram, as Director
-
Nov 22, 2026, 15:45Francine Freitas Fernandes: 3D and 4D Hysterosalpingo-Contrast Sonography
-
Nov 22, 2026, 15:25New RBMO Study Links Microfluidic Sperm Sorting to Higher Blastocyst Formation and Lower Miscarriage Rates
-
Nov 22, 2026, 15:21Michelle Mason: Pleased to Attend the Annual SWIGS Conference with the Care Fertility Cardiff Team
-
Nov 22, 2026, 15:18Rajeev Agarwal: The Lining Is 6.5 mm – Will the Embryo Transfer Fail?
-
Nov 22, 2026, 15:11The Automated IVF Laboratory Lecture by Jacques Cohen at the 5th Narture – Conceivable Life Sciences
-
Nov 22, 2026, 15:07Laura Rienzi: Same Message, 2 Slides – Which One Would You Rather See at a Congress?
